Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

NCT00603590 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

475

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Hypertension
Hyperlipidemia
Heart Disease

Interventions

DRUG: Polypill
DRUG: Placebo drug

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]